Literature DB >> 29769863

Influenza in Canada, 2012-2013 season.

E Wong1, Li Y Yan2, N Bastien2, C Sevenhuysen1, N Khalil1, B Winchester1, M Saboui1, T Mersereau1.   

Abstract

OBJECTIVE: This report summarizes influenza activity in Canada during the 2012-13 influenza season (August 26, 2012-August 24, 2013) from data obtained through the FluWatch surveillance program.
METHODS: FluWatch collected information from six primary indicators of influenza activity that describe the epidemiologic and virologic behaviour of influenza in Canada: sentinel laboratory-based influenza detections; strain characterization and antiviral resistance for circulating influenza viruses; primary care consultation rates of influenza-like illness; regional influenza activity levels; influenza-associated severe outcomes; and pharmacy surveillance.
RESULTS: The influenza season peaked nationally between late December 2012 and early January 2013 with influenza A(H3N2) identified as the predominant circulating influenza strain until early March, when influenza B became the predominant circulating strain. The cumulative reported hospitalization rates for all age groups were 25.0 per 100,000. Influenza A most greatly affected adults ≥65 years of age and influenza B most greatly affected children ≤19 years of age.
CONCLUSION: The influenza season was moderately severe. When compared to the previous two seasons, which were considered relatively mild, there was a significant increase in laboratory detections for influenza, as well as hospitalizations associated with influenza in 2012-13.

Entities:  

Year:  2014        PMID: 29769863      PMCID: PMC5933839          DOI: 10.14745/ccdr.v40i17a02

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  8 in total

1.  Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children.

Authors:  Dena L Schanzer; Joanne M Langley; Theresa W S Tam
Journal:  Pediatr Infect Dis J       Date:  2006-09       Impact factor: 2.129

2.  Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013.

Authors:  D M Skowronski; N Z Janjua; G De Serres; J A Dickinson; A-L Winter; S M Mahmud; S Sabaiduc; J B Gubbay; H Charest; M Petric; K Fonseca; P Van Caeseele; T L Kwindt; M Krajden; A Eshaghi; Y Li
Journal:  Euro Surveill       Date:  2013-01-31

3.  Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.

Authors:  E Kissling; M Valenciano; U Buchholz; A Larrauri; J M Cohen; B Nunes; J Rogalska; D Pitigoi; I Paradowska-Stankiewicz; A Reuss; S Jiménez-Jorge; I Daviaud; R Guiomar; J O'Donnell; G Necula; M Głuchowska; A Moren
Journal:  Euro Surveill       Date:  2014-02-13

4.  STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2012-08-01

5.  Estimating influenza deaths in Canada, 1992-2009.

Authors:  Dena L Schanzer; Claire Sevenhuysen; Brian Winchester; Teresa Mersereau
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

6.  Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada.

Authors:  Dena L Schanzer; Allison McGeer; Kathleen Morris
Journal:  Influenza Other Respir Viruses       Date:  2012-11-05       Impact factor: 4.380

7.  Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Authors:  Danuta M Skowronski; Naveed Z Janjua; Gaston De Serres; Suzana Sabaiduc; Alireza Eshaghi; James A Dickinson; Kevin Fonseca; Anne-Luise Winter; Jonathan B Gubbay; Mel Krajden; Martin Petric; Hugues Charest; Nathalie Bastien; Trijntje L Kwindt; Salaheddin M Mahmud; Paul Van Caeseele; Yan Li
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

8.  Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals.

Authors:  Dena L Schanzer; Joanne M Langley; Theresa W S Tam
Journal:  Influenza Other Respir Viruses       Date:  2008-01       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.